Longitudinal studies have also shown that NfL and P-tau181 change over time with disease progression.27,28 However, as a stand-alone biomarker, NfL lacks specificity for AD-related diagnoses, although NfL levels may identify individuals who will develop cognitive decline.29 Here, NEFL is linked to Alzheimer disease.